Overview of the 2022 WHO classification of neuroendocrine neoplasms
In this review, we detail the changes and the relevant features that are applied to neuroendocrine
neoplasms (NENs) in the 2022 WHO Classification of Endocrine and Neuroendocrine …
neoplasms (NENs) in the 2022 WHO Classification of Endocrine and Neuroendocrine …
[HTML][HTML] Mixed adenoneuroendocrine carcinomas (MANECs) of the gastrointestinal tract: an update
S La Rosa, A Marando, F Sessa, C Capella - Cancers, 2012 - mdpi.com
The systematic application of immunohistochemical techniques to the study of tumors has led
to the recognition that neuroendocrine cells occur rather frequently in exocrine neoplasms …
to the recognition that neuroendocrine cells occur rather frequently in exocrine neoplasms …
Mixed neuroendocrine-nonneuroendocrine neoplasms (MiNENs): unifying the concept of a heterogeneous group of neoplasms
S La Rosa, F Sessa, S Uccella - Endocrine pathology, 2016 - Springer
The wide application of immunohistochemistry to the study of tumors has led to the recognition
that epithelial neoplasms composed of both a neuroendocrine and nonneuroendocrine …
that epithelial neoplasms composed of both a neuroendocrine and nonneuroendocrine …
Gastric carcinoids and neuroendocrine carcinomas: pathogenesis, pathology, and behavior
G Rindi, C Bordi, S Rappel, S La Rosa, M Stolte… - World journal of …, 1996 - Springer
The goal of this study was to provide information of prognostic value for gastric endocrine
tumors. A total of 205 gastric endocrine tumors have been studied: 193 well differentiated …
tumors. A total of 205 gastric endocrine tumors have been studied: 193 well differentiated …
Immunomodulatory function of bone marrow-derived mesenchymal stem cells in experimental autoimmune type 1 diabetes
…, A Augello, A Vergani, S Dada, S La Rosa… - The journal of …, 2009 - journals.aai.org
Human clinical trials in type 1 diabetes (T1D) patients using mesenchymal stem cells (MSC)
are presently underway without prior validation in a mouse model for the disease. In …
are presently underway without prior validation in a mouse model for the disease. In …
ECL cell tumor and poorly differentiated endocrine carcinoma of the stomach: prognostic evaluation by pathological analysis
Background & Aims: Gastric endocrine tumors show a wide spectrum of clinical behavior,
and prognostic assessement of individual tumors is difficult. The aims of this work were to …
and prognostic assessement of individual tumors is difficult. The aims of this work were to …
[HTML][HTML] Somatostatin receptor type 2A immunohistochemistry in neuroendocrine tumors: a proposal of scoring system correlated with somatostatin receptor …
M Volante, MP Brizzi, A Faggiano, S La Rosa, I Rapa… - Modern Pathology, 2007 - Elsevier
Typing somatostatin receptor expression in neuroendocrine tumors is of relevance to target
somatostatin analogue-based diagnostic approach and treatment. The expanding use of …
somatostatin analogue-based diagnostic approach and treatment. The expanding use of …
Poorly differentiated neuroendocrine carcinomas of the pancreas: a clinicopathologic analysis of 44 cases
…, AM Krasinskas, E Vakiani, S La Rosa… - The American journal …, 2014 - journals.lww.com
Background: In the pancreas, poorly differentiated neuroendocrine carcinomas include small
cell carcinoma and large cell neuroendocrine carcinoma and are rare; data regarding their …
cell carcinoma and large cell neuroendocrine carcinoma and are rare; data regarding their …
The clinicopathologic heterogeneity of grade 3 gastroenteropancreatic neuroendocrine neoplasms: morphological differentiation and proliferation identify different …
…, F Sessa, E Solcia, C Capella, N Fazio, S La Rosa - …, 2016 - karger.com
… Stefano La Rosa Stefano La Rosa … La Rosa S, Sessa F: High-grade poorly differentiated
neuroendocrine carcinomas of the gastroenteropancreatic system: from morphology to …
neuroendocrine carcinomas of the gastroenteropancreatic system: from morphology to …
Histologic characterization and improved prognostic evaluation of 209 gastric neuroendocrine neoplasms
Gastric neuroendocrine neoplasms differ considerably in histology, clinicopathologic
background, stage, and patient outcome, implying a wide spectrum of therapeutic options, hence …
background, stage, and patient outcome, implying a wide spectrum of therapeutic options, hence …